Helene Boigard

Title: Helene Boigard: Innovator in Virus-Like Particle Technology

Introduction

Helene Boigard is a prominent inventor based in Elmsford, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of virus-like particles (VLPs) for flavivirus and alphavirus research. With a total of two patents to her name, her work has the potential to advance vaccine development and immunogenic compositions.

Latest Patents

Helene's latest patents focus on flavivirus and alphavirus virus-like particles (VLPs). These VLPs display antigenic flavivirus proteins on their surfaces, which are crucial for eliciting immune responses. The patents include a DNA construct that encodes flavivirus viral proteins, which are used to assemble the VLPs. Additionally, she has developed methods for producing these VLPs by introducing the DNA constructs into host cells. Her work also encompasses immunogenic compositions that incorporate the flavivirus VLPs, showcasing her innovative approach to vaccine technology.

Career Highlights

Helene Boigard has established herself as a key figure in her field through her innovative research and patent contributions. Her work at Technovax, Inc. has positioned her at the forefront of biotechnology, where she continues to explore the potential of VLPs in vaccine development. Her dedication to advancing scientific knowledge is evident in her successful patent applications.

Collaborations

Helene has collaborated with notable colleagues, including Jose M Galarza and George R Martin. These partnerships have enhanced her research efforts and contributed to the successful development of her patented technologies.

Conclusion

Helene Boigard's contributions to the field of biotechnology, particularly in the area of virus-like particles, highlight her innovative spirit and commitment to advancing vaccine technology. Her patents and collaborative efforts reflect her significant impact on the scientific community.